Viewing StudyNCT06340230



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06340230
Status: RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-25

Brief Title: SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER PositiveHER2 Low Breast Cancer
Sponsor: Shengjing Hospital
Organization: Shengjing Hospital

Conditions & Keywords Data

Conditions:
Name
ER PositiveHER2 Low Breast Cancer
Keywords:
Name View
SHR-A1811 View
Adebrelimab View
ER PositiveHER2 Low Breast Cancer View
Neoadjuvant View